January 1, 2021Open Access

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program

Key Points

Key points are not available for this paper at this time.

Abstract

siRNA protected mice from BLM-induced lung injuries and fibrosis. Together, our data support the possibility that MBD2 could be a viable target against PF in clinical settings.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Yi Wang

Anhui Medical University

Lei Zhang

Macau University of Science and Technology

Guorao Wu

Tongji Hospital

Journals

Science Advances

Actions

Institutions

Huazhong University of Science and Technology

Tongji Hospital

Shanghai Ninth People's Hospital

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Also consider